Colorectal organ metastasis is a secondary malignant tumor spreading from another primary cancer to the colon and rectal wall via hematogenous, lymphatic, or direct invasion routes. The most common primary sources are ovarian, gastric, breast, melanoma, and lung cancers. Peritoneal carcinomatosis (drop metastasis) is the most frequent spread mechanism — especially in ovarian and gastric cancers. Hematogenous spread is typically seen from melanoma, lung, and renal cancers. Direct invasion occurs from adjacent organ tumors (ovary, uterus, prostate, bladder). Focal or segmental wall thickening, peritoneal implants, and presence of known primary malignancy on CT are diagnostic clues. Colorectal metastasis generally indicates advanced-stage disease requiring systemic treatment approach.
Age Range
40-80
Peak Age
60
Gender
Equal
Prevalence
Uncommon
Colorectal metastasis occurs through three main spread routes. (1) Peritoneal carcinomatosis: Tumor cells from ovarian or gastric origin implant on the colonic serosa via peritoneal fluid and infiltrate the bowel wall from outside to inside (serosa → muscularis → mucosa). This process creates desmoplastic reaction developing wall stiffening + stricture + obstruction. (2) Hematogenous spread: Melanoma or lung cancer cells lodge in the submucosal capillary bed via arterial circulation, typically presenting as focal submucosal nodules or polypoid lesions. Melanoma's high vascularity causes prominent arterial phase enhancement. (3) Direct invasion: Adjacent organ tumors (ovary, uterus, prostate) directly invade the bowel wall from the serosal surface. Peritoneal implants, omental cake, and ascites accompanying the imaging findings support peritoneal carcinomatosis. The outside-in pattern of serosal irregularity and wall thickening on CT differs from the mucosal-dominant thickening of primary colorectal carcinoma.
In colorectal metastasis from peritoneal carcinomatosis, wall thickening progresses from the serosal surface inward — this outside-in pattern fundamentally distinguishes from the mucosal-dominant thickening of primary colorectal carcinoma. Serosal irregularity and surrounding peritoneal implants support the diagnosis.
In colorectal metastasis from peritoneal carcinomatosis, wall thickening starts from the serosal (outer) surface and progresses inward. The serosal surface is irregular with contrast uptake. Submucosal edema may create target sign. Thickening may be segmental or multifocal. The mucosal surface is usually preserved (in early stage) — different from mucosal ulceration/polypoid growth of primary adenocarcinoma.
Report Sentence
Serosal-dominant wall thickening with serosal irregularity in the colon/rectum is observed; in the context of known primary malignancy, metastatic involvement from peritoneal carcinomatosis should be considered.
Accompanying findings in the context of peritoneal carcinomatosis with colorectal involvement: peritoneal implants (nodular thickening on peritoneal surfaces), omental cake (thickened irregular appearance from diffuse infiltration of greater omentum), and ascites. These findings confirm that colorectal wall thickening originates from peritoneal spread. Rectovesical/rectouterine pouch (pouch of Douglas) involvement frequently accompanies.
Report Sentence
Peritoneal implants, omental cake, and ascites are observed; when evaluated together with colorectal wall thickening, these findings are consistent with peritoneal carcinomatosis.
In melanoma metastasis, prominently hypervascular enhancing submucosal nodule(s) in arterial phase. Nodules are usually round-oval, well-defined, and may show intraluminal polypoid growth. Target (bull's-eye) sign — enhancing peripheral ring with low-density center (ulceration/necrosis) — is the classic finding of melanoma metastasis. Multiple nodules may be distributed throughout the entire GI tract.
Report Sentence
Prominently hypervascular enhancing submucosal nodule(s) in the colon/rectum in arterial phase with target (bull's-eye) sign is observed; metastatic involvement should be considered with known melanoma history.
Colorectal metastasis shows variable signal on T2-weighted images — depending on the histology of the primary tumor. Mucinous tumor metastases (ovary, colon) show marked T2 hyperintensity (mucin content). Desmoplastic metastases (gastric linitis plastica) may appear hypointense on T2 (fibrous tissue dominance). Melanoma metastases may be T1 hyperintense (melanin effect) and T2 hypointense. MRI is superior to CT for evaluating local relationships in rectal metastases.
Report Sentence
Wall thickening with variable signal characteristics on T2-weighted images in the colon/rectum is observed, showing signal characteristics consistent with the histology of the primary tumor.
Diffusion restriction in metastatic deposits on DWI — hyperintense signal at high b-value and low signal on ADC map. DWI detects small peritoneal implants with higher sensitivity than CT. Subcapsular and pelvic peritoneal implants are particularly better visualized on DWI than conventional CT/MR sequences. DWI is also useful for evaluating treatment response.
Report Sentence
Diffusion restriction in peritoneal implants and colorectal wall thickening on DWI is observed, consistent with metastatic involvement.
Colorectal metastatic deposits show variable FDG uptake on FDG PET-CT depending on the metabolic activity of the primary tumor. Prominent uptake in high-grade tumor metastases, while mucinous metastases may show lower uptake. PET-CT plays a critical role in determining disease extent and evaluating treatment response. Simultaneous evaluation of primary tumor + colorectal metastasis + other metastatic sites provides comprehensive staging.
Report Sentence
FDG uptake in colorectal wall thickening on PET-CT is observed; metastatic involvement should be considered in the context of known primary malignancy.
Criteria
Most common spread mechanism. Ovarian, gastric, colorectal primary sources. Serosal-dominant wall thickening, peritoneal implants, omental cake, ascites.
Distinct Features
Multifocal segmental colorectal involvement is common. Pouch of Douglas and rectosigmoid region are frequently involved. Serosal surface is irregular with enhancement. Small bowel and other peritoneal surfaces may also be involved. HIPEC (hyperthermic intraperitoneal chemotherapy) may be a treatment option.
Criteria
Lodging in submucosal capillary bed via arterial circulation. Focal submucosal nodules or polypoid lesions. Hypervascular enhancement and bull's-eye sign in melanoma.
Distinct Features
Usually multifocal, may be distributed throughout the entire GI tract. Melanoma metastases are hypervascular with prominent enhancement. Lung and renal metastases typically in advanced-stage disease. May present with intraluminal bleeding.
Criteria
Direct extension from adjacent organ tumors (ovary, uterus, prostate, bladder). Obliteration of fat planes and loss of organ-bowel interface.
Distinct Features
Focal, single-region involvement is typical. Continuity between primary tumor and colorectal involvement. Serosal invasion → muscularis infiltration → mucosal involvement sequence. Rectum is the most commonly involved segment (from pelvic tumors).
Distinguishing Feature
Primary adenocarcinoma shows mucosal-dominant thickening, intraluminal polypoid growth, and luminal narrowing; metastasis shows serosal-dominant thickening. Adenocarcinoma is usually solitary; metastasis may be multifocal. Peritoneal implants and omental cake support metastasis.
Distinguishing Feature
Lymphoma shows homogeneous circumferential thickening and aneurysmal dilatation; metastasis shows serosal irregularity and peritoneal findings. Lymphoma is associated with mesenteric LAP; metastasis with peritoneal implants and omental cake.
Distinguishing Feature
GIST grows as solitary exophytic heterogeneous mass; metastasis shows multifocal segmental involvement. Peritoneal findings are late in GIST; frequently accompany metastasis.
Distinguishing Feature
Crohn disease presents in young patients with skip lesions, fistulas, and creeping fat; metastasis presents with known malignancy, peritoneal implants, and ascites. Clinical context is distinguishing.
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralColonoscopic biopsy is required for colorectal metastasis diagnosis — histopathological confirmation determines the primary tumor origin and treatment planning. Treatment is directed at the primary tumor; colorectal metastasis generally responds to systemic chemotherapy. HIPEC (hyperthermic intraperitoneal chemotherapy) + cytoreductive surgery may be considered in selected patients with peritoneal carcinomatosis. Stenting or bypass surgery may be needed for obstruction. Immunotherapy (anti-PD-1, anti-CTLA-4) may be effective in melanoma GI metastases. Follow-up: staging and treatment protocol according to primary tumor. Prognosis is generally poor — colorectal metastasis indicates advanced-stage disease.
Indicates systemic disease. Requires primary tumor treatment and staging workup. Solitary metastasis may be amenable to surgery. PET-CT for extent assessment.